Skip to main content

Table 1 Summary of available clinical, histologic, and molecular data from each astrocytoma subgroup analyzed

From: Total copy number variation as a prognostic factor in adult astrocytoma subtypes

Group

Tumor Type

n

Age at Onset (years)

Median Progression-Free Survival (months)

Median Overall Survival (months)

Histologic Grade (II/III/IV)

CNV Level (%)

Cases with Chromothripsis

Mutation Count

Instability Gene Mutations

1

IDH-mut LGG

24

38.8 ± 1.9

95

> 172

12/12/0

9.1 ± 1.6

2 (8.3%)

43 ± 10.5

1 (4.1%)

2

IDH-mut CDK4/

         

CDKN2A/B LGG

22

38.8 ± 1.9

32

36

4/18/0

21.3 ± 2.5

6 (27.3%)

33.3 ± 1.3

7 (31.8%)

3

IDH-mut GBM

22

40.5 ± 2.7

10

33

0/0/22

20 ± 2.7

9 (40.9%)

67.4 ± 2.75

8 (36.4%)

4

IDH-wt LGG

25

54.0 ± 2.6

10.5

15.5

0/25/0

19.9 ± 1.8

5 (20.0%)

64.9 ± 16.7

5 (20.0%)

5

IDH-wt GBM

42

62.8 ± 1.7

6

13

0/0/42

22.2 ± 1.6

11 (26.2%)

57.0 ± 2.5

10 (23.8%)